|
|
|
Enlightened
understanding for pipeline product forecasting
|
|
|
|
|
|
|
The Analogue service aids new
product forecasting by providing benchmark models for launch
and post launch performance, based on the history and experience
of recent launches.
|
|
|
|
|
The Analogue database holds
penetration curves for over 2000 branded products launched
in the retail sector since 1992 and spanning 150 therapy classes
(ATC4 level). Each country holds an average of 250 brands
from which benchmark models can be selected.
Included in the service;
|
|
Penetration Curves - by revenue and prescriptions
|
|
|
Product Characteristics
- launch date, price,
promotional expenditure as a ratio to sales, the effects
of co-marketing, reimbursement status, product rating
|
|
|
Market Criteria - Chronic/acute,
satisfied/unsatisfied needs, growing/declining….
|
|
|
Country Coverage - USA, Japan,
Germany, UK, France, Italy, Spain, Canada, Japan.
|
|
Country
Reports - provides insight into the key drivers
influencing product uptake by profiling the leading
new products launched in each country. Sample
report |
|
|
International
Standards - able to compare across countries and
drill down into specific country |
| |
Updated
every 6 months - reflects the innovative and dynamic
healthcare marketplace |
|
|
|
|
|
Analogue identifies the drivers
contributing to successful product launches, providing a valuable
benchmark for the expected performance of a new drug. Additional
insight into country launches is provided by case studies
and key events.
Analogue is supplied as an interactive database allowing you
to select new product benchmark models based on 15 selection
criteria and enables you to;
|
|
create "What if" scenarios by changing elements of the
marketing mix
|
|
|
develop
new product forecasts based using the selected benchmarks
as models for the growth likely to be achieved under current
market conditions
|
|
|
|
|
|
For further
details please contact IMS HEALTH at +44(0)207 393 5757
Download
a
ScreenCam demo.
Request further information
- click
here...
|
|
|
|
